QQQ   357.86 (-1.83%)
AAPL   173.93 (-0.89%)
MSFT   319.53 (-0.39%)
META   295.73 (-1.31%)
GOOGL   130.44 (-2.47%)
AMZN   129.33 (-4.41%)
TSLA   255.70 (-2.62%)
NVDA   410.17 (-2.89%)
NIO   8.46 (-4.19%)
BABA   84.12 (-1.89%)
AMD   96.11 (-4.22%)
T   15.31 (-1.61%)
F   12.20 (-1.30%)
MU   67.90 (-2.55%)
CGC   0.77 (-11.53%)
GE   112.97 (-1.64%)
DIS   82.73 (+0.21%)
AMC   7.71 (-5.51%)
PFE   32.85 (-2.29%)
PYPL   58.62 (-3.68%)
NFLX   384.15 (-0.56%)
QQQ   357.86 (-1.83%)
AAPL   173.93 (-0.89%)
MSFT   319.53 (-0.39%)
META   295.73 (-1.31%)
GOOGL   130.44 (-2.47%)
AMZN   129.33 (-4.41%)
TSLA   255.70 (-2.62%)
NVDA   410.17 (-2.89%)
NIO   8.46 (-4.19%)
BABA   84.12 (-1.89%)
AMD   96.11 (-4.22%)
T   15.31 (-1.61%)
F   12.20 (-1.30%)
MU   67.90 (-2.55%)
CGC   0.77 (-11.53%)
GE   112.97 (-1.64%)
DIS   82.73 (+0.21%)
AMC   7.71 (-5.51%)
PFE   32.85 (-2.29%)
PYPL   58.62 (-3.68%)
NFLX   384.15 (-0.56%)
QQQ   357.86 (-1.83%)
AAPL   173.93 (-0.89%)
MSFT   319.53 (-0.39%)
META   295.73 (-1.31%)
GOOGL   130.44 (-2.47%)
AMZN   129.33 (-4.41%)
TSLA   255.70 (-2.62%)
NVDA   410.17 (-2.89%)
NIO   8.46 (-4.19%)
BABA   84.12 (-1.89%)
AMD   96.11 (-4.22%)
T   15.31 (-1.61%)
F   12.20 (-1.30%)
MU   67.90 (-2.55%)
CGC   0.77 (-11.53%)
GE   112.97 (-1.64%)
DIS   82.73 (+0.21%)
AMC   7.71 (-5.51%)
PFE   32.85 (-2.29%)
PYPL   58.62 (-3.68%)
NFLX   384.15 (-0.56%)
QQQ   357.86 (-1.83%)
AAPL   173.93 (-0.89%)
MSFT   319.53 (-0.39%)
META   295.73 (-1.31%)
GOOGL   130.44 (-2.47%)
AMZN   129.33 (-4.41%)
TSLA   255.70 (-2.62%)
NVDA   410.17 (-2.89%)
NIO   8.46 (-4.19%)
BABA   84.12 (-1.89%)
AMD   96.11 (-4.22%)
T   15.31 (-1.61%)
F   12.20 (-1.30%)
MU   67.90 (-2.55%)
CGC   0.77 (-11.53%)
GE   112.97 (-1.64%)
DIS   82.73 (+0.21%)
AMC   7.71 (-5.51%)
PFE   32.85 (-2.29%)
PYPL   58.62 (-3.68%)
NFLX   384.15 (-0.56%)
LON:SN

Smith & Nephew (SN) Share Forecast, Price & News

GBX 1,051.50
+11.00 (+1.06%)
(As of 09/20/2023 ET)
Compare
Today's Range
1,044
▼
1,061.50
50-Day Range
1,036.50
▼
1,203.50
52-Week Range
959.20
▼
1,316.75
Volume
1.48 million shs
Average Volume
343,671 shs
Market Capitalization
£9.18 billion
P/E Ratio
5,257.50
Dividend Yield
2.85%
Price Target
GBX 1,444.40
ProfileAnalyst RatingsChartCompetitorsDividendInsider TradesHeadlinesOptions ChainSustainability

Smith & Nephew MarketRank™ Forecast

Analyst Rating
Moderate Buy
2.50 Rating Score
Upside/​Downside
37.4% Upside
GBX 1,444.40 Price Target
Short Interest
N/A
Dividend Strength
Weak
Based on Four Factors
Sustainability
-1.95
Upright™ Environmental Score
News Sentiment
0.97mentions of Smith & Nephew in the last 14 days
Based on 2 Articles This Week
Insider Trading
Acquiring Shares
£5.88 M Bought Last Quarter
Proj. Earnings Growth
N/A

Overall MarketRank™

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.57 out of 5 stars

See Top Rated MarketRank™ Stocks Here

SN stock logo

About Smith & Nephew (LON:SN) Stock

Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom and internationally. The company operates through three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. The company offers knee implant products for knee replacement procedures; hip implants for revision procedures; and trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures. It also provides sports medicine joint repair products, including instruments, technologies, and implants to perform minimally invasive surgery of the joints, such as the repair of soft tissue injuries and degenerative conditions of the shoulder, knee, hip, and small joints. In addition, the company offers arthroscopic enabling technologies comprising fluid management equipment for surgical access, high-definition cameras, digital image capture, scopes, light sources, and monitors to assist with visualization inside the joints, radio frequency, electromechanical and mechanical tissue resection devices, and hand instruments for removing damaged tissue; and ear, nose, and throat solutions. Further, it provides advanced wound care products for the treatment and prevention of acute and chronic wounds, which comprise leg wounds, diabetic and pressure ulcers, burns, and post-operative wounds; advanced wound bioactives, such as biologics and other bioactive technologies for debridement and dermal repair/regeneration, as well as regenerative medicine products, including skin, bone graft, and articular cartilage substitutes; and advanced wound devices, such as traditional and single-use negative pressure wound therapy, and hydrosurgery systems. It primarily serves the healthcare providers. Smith & Nephew plc was founded in 1856 and is headquartered in Watford, the United Kingdom.

SN Price History

SN Stock News Headlines

September 17, 2023 | americanbankingnews.com
Smith & Nephew plc (LON:SN) Receives Consensus Recommendation of "Moderate Buy" from Brokerages
September 13, 2023 | finance.yahoo.com
Are Investors Undervaluing Smith & Nephew SNATS (SNN) Right Now?
September 21, 2023 | Chaikin Analytics (Ad)
Buy This Stock for AI Tidal Wave (not NVDA)
The internet boom made more millionaires than any tech  - Microsoft’s CEO says AI has even more potential. Here’s the #1 stock to buy.
September 6, 2023 | finance.yahoo.com
SN.L - Smith & Nephew plc
September 4, 2023 | msn.com
Smith & Nephew (SNN) Loses -5.98% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
August 16, 2023 | finance.yahoo.com
Is Smith & Nephew plc's (LON:SN.) Stock On A Downtrend As A Result Of Its Poor Financials?
August 3, 2023 | msn.com
Smith+Nephew raises annual revenue outlook
August 3, 2023 | msn.com
Smith+Nephew profit margins disappoint after revenue beat
September 21, 2023 | Chaikin Analytics (Ad)
Buy This Stock for AI Tidal Wave (not NVDA)
The internet boom made more millionaires than any tech  - Microsoft’s CEO says AI has even more potential. Here’s the #1 stock to buy.
August 1, 2023 | msn.com
Smith & Nephew: Entering New Markets But Growth Is Slow Still
August 1, 2023 | uk.movies.yahoo.com
Earnings incoming: are Smith & Nephew shares about to take off?
July 12, 2023 | finance.yahoo.com
Tree Island Steel to Issue Second Quarter 2023 Financial Results on July 27, 2023
July 8, 2023 | fool.com
Smith & Nephew Plc (LSE: SN)
July 3, 2023 | uk.style.yahoo.com
Are these 2 FTSE 100 stocks among the best shares to buy today?
June 14, 2023 | marketwatch.com
Smith & Nephew rises Wednesday, outperforms market
May 19, 2023 | lse.co.uk
Smith & Nephew Regulatory News (SN.)
May 16, 2023 | finance.yahoo.com
Smith+Nephew helps personalize robotically-enabled surgery with AI-powered planning software and data visualization platform
May 14, 2023 | msn.com
Smith & Nephew: Need Strong Rotation Of Capital Into Market Value For FY23
May 11, 2023 | marketwatch.com
Smith & Nephew rises Thursday, outperforms market
May 5, 2023 | marketwatch.com
Smith & Nephew falls Friday, underperforms market
May 3, 2023 | msn.com
Up 17% last month, should I buy this soaring FTSE 100 growth stock?
May 2, 2023 | finance.yahoo.com
Smith+Nephew receives Innovative Technology contract from Vizient for PICO™ Single Use Negative Pressure Wound Therapy Systems
April 26, 2023 | markets.businessinsider.com
Smith+Nephew Q1 Revenues Rise; Maintains FY23 View
April 24, 2023 | finanznachrichten.de
Smith & Nephew plc: Smith+Nephew introduces first of its kind handheld digital tensioning device for robotically-enabled total knee arthroplasty
April 9, 2023 | finance.yahoo.com
Shareholders in Smith & Nephew (LON:SN.) are in the red if they invested three years ago
March 7, 2023 | finanznachrichten.de
Smith & Nephew plc: Smith+Nephew unveils 'Precision in Motion' for its Orthopaedics Arthroplasty portfolio at AAOS 2023 Annual Meeting
March 7, 2023 | finance.yahoo.com
Smith+Nephew unveils 'Precision in Motion' for its Orthopaedics Arthroplasty portfolio at AAOS 2023 Annual Meeting
See More Headlines
Receive SN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Smith & Nephew and its competitors with MarketBeat's FREE daily newsletter.

SN Company Calendar

Today
9/21/2023
Ex-Dividend for 11/1 Dividend
10/05/2023
Dividend Payable
11/01/2023
Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange
LON
Industry
Medical Devices
Sub-Industry
N/A
Sector
Medical
Current Symbol
LON:SN
CUSIP
N/A
CIK
N/A
Web
www.smith-nephew.com
Phone
+44-20-74017646
Fax
N/A
Employees
19,000
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
GBX 1,444.40
High Stock Price Forecast
GBX 1,612
Low Stock Price Forecast
GBX 1,200
Forecasted Upside/Downside
+37.4%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.50
Research Coverage
6 Analysts

Profitability

EPS (Most Recent Fiscal Year)
GBX 0.20
Trailing P/E Ratio
5,257.50
Forward P/E Ratio
13.40
P/E Growth
0.44
Net Income
£218 million
Net Margins
4.07%
Pretax Margin
N/A
Return on Equity
4.10%
Return on Assets
4.37%

Debt

Debt-to-Equity Ratio
58.09
Current Ratio
2.19
Quick Ratio
0.84

Sales & Book Value

Annual Sales
£5.35 billion
Price / Sales
1.72
Cash Flow
GBX 56.28 per share
Price / Cash Flow
18.68
Book Value
GBX 599 per share
Price / Book
1.76

Miscellaneous

Outstanding Shares
873,390,000
Free Float
N/A
Market Cap
£9.18 billion
Optionable
Optionable
Beta
0.42
(Almost) Everything You Need To Know About The EV Market Cover
(Almost) Everything You Need To Know About The EV Market

Click the link below and we'll send you MarketBeat's guide to investing in electric vehicle technologies (EV) and which EV stocks show the most promise.

Get This Free Report

Key Executives

  • Dr. Deepak S. Nath Ph.D. (Age 51)
    CEO & Director
    Comp: $5.96M
  • Ms. Anne-Francoise Nesmes (Age 51)
    CFO & Exec. Director
    Comp: $1.35M
  • Mr. Paul Connolly (Age 55)
    Pres of Global Operations
  • Mr. Andrew Swift
    VP of Investor Relations
  • Ms. Helen Barraclough (Age 43)
    Group Gen. Counsel & Company Sec.
  • Ms. Alison Parkes (Age 50)
    Chief Compliance Officer & Compliance APAC
  • Mr. Joe Metzger
    Sr. VP of Marketing Services & Communications
  • Mr. Philip G. Cowdy (Age 56)
    Chief Corp. Devel. & Corp. Affairs Officer
  • Ms. Elga Lohler (Age 55)
    Chief HR Officer
  • Mr. Bradley Cannon (Age 55)
    Pres of Global Orthopaedics

Key Competitors

View All Competitors

Insiders

View All Insider Transactions













SN Stock - Frequently Asked Questions

Should I buy or sell Smith & Nephew stock right now?

6 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Smith & Nephew in the last twelve months. There are currently 1 sell rating, 1 hold rating and 4 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "moderate buy" SN shares.
View SN analyst ratings or view top-rated stocks.

What is Smith & Nephew's stock price forecast for 2023?

6 brokers have issued 1-year price targets for Smith & Nephew's stock. Their SN share price forecasts range from GBX 1,200 to GBX 1,612. On average, they expect the company's stock price to reach GBX 1,444.40 in the next year. This suggests a possible upside of 37.4% from the stock's current price.
View analysts price targets for SN or view top-rated stocks among Wall Street analysts.

How have SN shares performed in 2023?

Smith & Nephew's stock was trading at GBX 1,109.50 at the start of the year. Since then, SN stock has decreased by 5.2% and is now trading at GBX 1,051.50.
View the best growth stocks for 2023 here.

How often does Smith & Nephew pay dividends? What is the dividend yield for Smith & Nephew?

Smith & Nephew announced a dividend on Thursday, August 3rd. Stockholders of record on Thursday, October 5th will be paid a dividend of GBX 0.14 per share on Wednesday, November 1st. This represents a yield of 0.98%. The ex-dividend date is Thursday, October 5th. The official announcement can be accessed at this link.
Read our dividend analysis for SN.

Is Smith & Nephew a good dividend stock?

Smith & Nephew (LON:SN) pays an annual dividend of GBX 30 per share and currently has a dividend yield of 2.83%. The dividend payout ratio is 15,000.00%. Payout ratios above 75% are not desirable because they may not be sustainable.
Read our dividend analysis for SN.

What other stocks do shareholders of Smith & Nephew own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Smith & Nephew investors own include Imperial Brands (IMB), Smith & Nephew (SNN), Alexion Pharmaceuticals (ALXN), Barclays (BARC), GSK (GSK), Diageo (DGE), Standard Chartered (STAN), Unilever (ULVR), British American Tobacco (BATS) and BHP Group (BHP).

What is Smith & Nephew's stock symbol?

Smith & Nephew trades on the London Stock Exchange (LON) under the ticker symbol "SN."

How do I buy shares of Smith & Nephew?

Shares of SN stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

What is Smith & Nephew's stock price today?

One share of SN stock can currently be purchased for approximately GBX 1,051.50.

How much money does Smith & Nephew make?

Smith & Nephew (LON:SN) has a market capitalization of £9.18 billion and generates £5.35 billion in revenue each year. The company earns £218 million in net income (profit) each year or GBX 0.20 on an earnings per share basis.

How many employees does Smith & Nephew have?

The company employs 19,000 workers across the globe.

How can I contact Smith & Nephew?

Smith & Nephew's mailing address is 15 Adam Street, LONDON, WC2N 6LA, United Kingdom. The official website for the company is www.smith-nephew.com. The company can be reached via phone at +44-20-74017646.

This page (LON:SN) was last updated on 9/21/2023 by MarketBeat.com Staff

My Account -